Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in High-Risk Prostate Cancer
NCT01832259Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in prostate cancer (PCa), sponsored by University of Utah. Started Aug 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01832259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01832259.